Some key osteogenic markers (OCN, BSP, and OSX) were recovered in the CLH-treated group, underscoring the gel’s dual role in improving bone microstructure, providing a foundation for its therapeutic potential in periodontitis. This evidence concerns the gene IBSP and periodontitis.